InstantGMP™, the leading provider of software solutions for
pharmaceutical manufacturing to ensure Good Manufacturing Practice
(GMP) and FDA compliance, is thrilled to announce our newest
client, Aura Biosciences. Aura Biosciences is at the forefront of
oncology therapeutics with their innovative Virus-like Drug
Conjugates (VDCs) platform that utilizes Virus-Like Particles
(VLPs) derived from human papillomavirus (HPV) to target a broad
range of solid tumors
CARY,
N.C., July 22, 2024 /PRNewswire-PRWeb/ --
InstantGMP™, the leading provider of software solutions for
pharmaceutical manufacturing to ensure Good Manufacturing Practice
(GMP) and FDA compliance, is thrilled to announce our newest
client, Aura Biosciences.
"Partnering with InstantGMP has provided us
with the tools to ensure that our research and development
processes are not only efficient but also more effective," stated
Ryan Clarke, Senior Manager Quality
Systems at Aura Biosciences.
Aura Biosciences is at the forefront of oncology therapeutics
with their innovative Virus-like Drug Conjugates (VDCs) platform
that utilizes Virus-Like Particles (VLPs) derived from human
papillomavirus (HPV) to target a broad range of solid tumors.
To streamline their research and development processes, Aura
Biosciences has invested in InstantGMP's Quality Management System
(QMS). The QMS software system enables Aura Biosciences to
meticulously manage the quality of their clinical research,
ensuring that the drug conjugates they create are carefully
controlled and compliant with the highest standards.
"Our QMS is designed to support Aura Biosciences' innovative
approach to cancer treatment by providing a centralized platform
for managing specifications, deviation tracking, root cause
identification, and investigations. This systematic approach to
quality assurance ensures that every step of their process is
meticulously documented and controlled," said Dr. Richard Soltero, President of InstantGMP.
"Partnering with InstantGMP has provided us with the tools to
ensure that our research and development processes are not only
efficient but also more effective," stated Ryan Clarke, Senior Manager Quality Systems at
Aura Biosciences.
InstantGMP is excited to see the advancements Aura Biosciences
will achieve with the support of our QMS. This partnership
underscores our commitment to providing top-tier quality management
solutions for innovative companies in the clinical research and
development industries. We look forward to contributing to Aura
Biosciences' success in developing groundbreaking oncology
therapeutics.
To learn more about InstantGMP QMS and the solutions it provides
for clinical research quality assurance processes, please contact
us to schedule a demonstration of our software system.
About InstantGMP™, Inc.
Founded by pharmaceutical industry veteran Dr. Richard Soltero, InstantGMP, Inc., offers
affordable all-in-one manufacturing, inventory and quality
software. The company develops cloud-based electronic batch record
software and standard operating procedures specific to industries
that are required to follow FDA manufacturing regulations and Good
Manufacturing Practices ("GMP").
As a manufacturing software company, InstantGMP™ pioneered
accessible, easy-to-use electronic batch record software for
products manufactured using GMPs. The Company's updated software
simplifies the documentation and approval procedures for quality
processes that keep all quality documentation organized in
electronic format while providing for quality checks and workflow
processes to make compliance with FDA requirements easy.
Media Contact
Jeremy Hall, InstantGMP Inc.,
919-645-1073, jhall@instantgmp.com, www.instantgmp.com
Robert Pochadt, InstantGMP Inc.,
919-645-1072, rpochadt@instantgmp.com
Twitter
View original content to download
multimedia:https://www.prweb.com/releases/aura-biosciences-invests-in-instantgmp-qms-for-clinical-research-quality-assurance-302200336.html
SOURCE InstantGMP Inc.